Cybin Inc. (HELP)

NASDAQ: HELP · USD

$10.9

+0.38 (+3.6%)· Recorded snapshot

Market cap	796.4M
Net income (ttm)	-171.2M
EPS (ttm)	-$4.05
Shares out	73.1M
Volume	595,719
Beta	0.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -171.2M
EPS (ttm): -$4.05
Market cap: 796.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-86.9

P25 n/aP50 n/aP75 n/a

ROIC-47.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All HELP indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001833141
Company name	Cybin Inc.
Country	Canada
Country code	US
CUSIP number	423492107
Earnings date	2026-11-12
Earnings time	bmo
Employees	100
Employees change	50
Employees growth	100%
Enterprise value	$630M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	March
Founded	2019
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	CA4234921076
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2024-09-19
Last stock split type	Reverse
Market cap	$796.4M
Market cap category	Small-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$10.90
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	HELP
Website	https://www.helus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-37.15%
FCF / EV yield	-22.71%
FCF yield	-17.91%
P/B ratio	2.69x
Price / tangible book value	4.48x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-1.7M
ROA	-44.38%
ROA (5Y)	-38.81%
ROCE	-69%
ROE	-86.94%
ROE (5Y)	-64.91%
ROIC	-47.63%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$34,000
Depreciation and amortization	$109,000
EBIT	$-167M
EBITDA	$-166.9M
EPS	$-4.05
FCF per share	$-1.93
Financing cash flow	$190.1M
Free cash flow	$-140.8M
Free cash flow minus SBC	$-162.4M
Investing cash flow	$-1.5M
Net borrowing	$-20.2M
Net cash flow	$47.7M
Net income	$-171.2M
Operating cash flow minus SBC	$-162.5M
Operating income	$-167M
Stock-based compensation	$21.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$3.91
Debt / equity	0
Goodwill	$36.2M
Long-term assets	$67M
Long-term liabilities	$0
Net cash (debt)	$166.4M
Net cash / market cap	21.16%
Net cash growth	124.24%
Net debt / equity	-0.69
Piotroski F-Score	2
Property, plant and equipment	$180,000
Shareholders' equity	$242.1M
Tangible book value	$175.3M
Tangible book value per share	$2.83
Total assets	$259.7M
Total cash	$166.4M
Total debt	$0
Total liabilities	$17.6M
WACC	7.22%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$192.7M
Current liabilities	$17.6M
Current ratio	10.97
Net working capital	$8.8M
Quick ratio	9.76
Working capital	$175.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-103.06%
Dividend yield	0%
Shareholder yield	-103.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$8.09
1D price change	3.61%
1M price change	-14.43%
1M total return	-14.43%
1W price change	-1.37%
1W total return	-1.37%
1Y price change	65.75%
1Y return CAGR	65.8%
1Y total return	65.75%
20-day SMA	$10.86
200-day SMA	$7.69
3M price change	40.13%
3M total return	40.13%
3Y price change	-54.13%
3Y return CAGR	-22.87%
3Y total return	-54.13%
50-day SMA	$12.02
50-day SMA vs 200-day SMA	50over200
52-week high	$15.15
52-week high date	2026-09-18
52-week low	$3.76
52-week low date	2026-06-09
5Y price change	-85.06%
5Y return CAGR	-31.63%
5Y total return	-85.06%
6M price change	99.82%
6M total return	99.82%
All-time high	$128.44
All-time high date	2021-08-02
All-time low	$3.76
All-time low date	2026-06-09
Average true range (ATR)	$0.89
Average volume	1.5M
Beta (1Y)	2.66
Beta (2Y)	1.53
Beta (5Y)	0.54
Change from 52-week high	-28.05%
Change from 52-week low	189.89%
Change from all-time high	-91.6%
Change from all-time low	186.97%
Change from open	2.54%
Day's gap	1.05%
Dollar volume	$6.5M
High price	$10.91
Low price	$10.50
Monthly RSI	53.01
Open price	$10.63
Position in 52-week range	97.56%
Premarket change	2.38%
Premarket close	$10.52
Premarket price	$10.77
Premarket volume	12.4K
Previous close	$10.52
Price vs 150-day SMA	33.31%
Price vs 20-day SMA	-0.6%
Price vs 200-day SMA	40.37%
Price vs 50-day SMA	-10.23%
Relative volume	0.4
RSI	46.41
Sharpe ratio	0.99
Sharpe ratio (3Y)	0.1
Sharpe ratio (5Y)	-0.13
Sortino ratio	1.51
Sortino ratio (3Y)	0.22
Sortino ratio (5Y)	-0.13
Volume	595.7K
Weekly RSI	57.89
YTD price change	31.91%
YTD total return	31.91%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58.1M
Float percentage	79.52%
Shares change (QoQ)	4.63%
Shares change (YoY)	103.06%
Shares held by insiders	15.21%
Shares held by institutions	39.01%
Shares outstanding	73.1M
Short % of float	5.18%
Short % of shares	4.12%
Short ratio	2 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	126

Deeper analysis on HELP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this HELP report

Is a complete HELP research report available?

No complete published report is available for Cybin Inc. (HELP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cybin Inc. (HELP)

Price

Financial snapshot

Fair-value bridge

Latest news · HELP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HELP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on HELP

Frequently asked questions